Vitality Watch

Dossier rss preclinical 26-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction

Key claim: Hepatocyte-specific ablation of the growth hormone receptor is associated with aging phenotypes and hepatic mitochondrial dysfunction.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Systemic GH/IGF-1 reduction is one of the most reproducible longevity levers across models, but this finding localizes part of that signal to hepatocyte-autonomous GH receptor loss — with hepatic mitochondrial dysfunction as a co-occurring lesion rather than an unambiguous benefit. That complicates the clean ‘less GH = longer life’ narrative used to justify GH-axis suppression, since the same receptor loss in liver couples to mitochondrial impairment and aging phenotypes. It sharpens where in the GH axis interventions should and shouldn’t act.

Source

Link

Briefing card

Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction
Stage: preclinical · rss · 26-sep-2026

If you follow GH/IGF-1 suppression as a longevity strategy, this mouse study shows that removing GH signaling specifically in liver produced aging phenotypes and mitochondrial dysfunction rather than a clean benefit.

Hepatocyte-specific ablation of the growth hormone receptor is associated with aging phenotypes and hepatic mitochondrial dysfunction.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70741?af=R

build build 880 · 2bcef25 · 2026-11-18